VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature.
about
Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrierAmbulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatmentTumor refractoriness to anti-VEGF therapyThyroid Hormones as Renal Cell Cancer RegulatorsPrognostic significance of adverse events in patients with hepatocellular carcinoma treated with sorafenibTyrosine kinase inhibitors induced thyroid dysfunction: a review of its incidence, pathophysiology, clinical relevance, and treatmentLeptin and its cardiovascular effects: Focus on angiogenesisMicrovascular repair: post-angiogenesis vascular dynamicsChoroid plexus in developmental and evolutionary perspectivePractical management of bevacizumab-related toxicities in glioblastomar84, a novel therapeutic antibody against mouse and human VEGF with potent anti-tumor activity and limited toxicity inductionDLL4 promotes continuous adult intestinal lacteal regeneration and dietary fat transport.The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study.Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer PatientsGastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation TherapyEffects of anti-VEGF on predicted antibody biodistribution: roles of vascular volume, interstitial volume, and blood flowVascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.Computed tomography imaging of primary lung cancer in mice using a liposomal-iodinated contrast agentTargeting the vascular endothelial growth factor pathway in the treatment of human malignancy.Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial.Vascular endothelial growth factor as an anti-angiogenic target for cancer therapyOverexpression of VEGF165b in podocytes reduces glomerular permeability.Designing a broad-spectrum integrative approach for cancer prevention and treatment.Factors regulating capillary remodeling in a reversible model of inflammatory corneal angiogenesisThe biomechanical properties of an epithelial tissue determine the location of its vasculatureSubthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathyEndogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptorsDominant effect of antiangiogenesis in combination therapy involving cyclophosphamide and axitinibBlockade of VEGFR2 and not VEGFR1 can limit diet-induced fat tissue expansion: role of local versus bone marrow-derived endothelial cellsEndoscopy in patients with diarrhea during treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitors: Is the cause in the mucosa?Prolonged blockade of VEGF family members does not cause identifiable damage to retinal neurons or vessels.Neutralizing endogenous VEGF following traumatic spinal cord injury modulates microvascular plasticity but not tissue sparing or functional recovery.Local acting Sticky-trap inhibits vascular endothelial growth factor dependent pathological angiogenesis in the eye.Expression and localization of angiogenic growth factors in developing porcine mesonephric glomeruli.Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitorsDiverse roles of the vasculature within the neural stem cell niche.The VEGF family in cancer and antibody-based strategies for their inhibition.VEGFR2 but not VEGFR3 governs integrity and remodeling of thyroid angiofollicular unit in normal state and during goitrogenesis.Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors.Thyroid autoimmunity and ophthalmopathy related to melanoma biological therapy
P2860
Q24644639-6FC273DF-2229-4AF9-93D7-3A1681010DE0Q24657761-7E8A81CE-83E6-44A3-A05A-8D600E449EFAQ26747678-B669B04D-B92E-405E-B69A-C9208CF27180Q26748991-264269FD-2445-44DB-A3FD-78551E045443Q26765210-29A257C7-3EE3-49C2-A12B-B675E40FCA59Q26998914-E02506D6-DA5E-4488-9712-D3BB1531B7DFQ27000027-48E6C0A5-141D-4178-93F2-B5DAC2A59847Q27004093-3A60AE1F-8389-400D-8CA8-96D00777A62AQ27011140-620D8408-6FBB-4850-8525-E4270C0EAE12Q27015852-8717BF91-033E-4D38-BF42-47B1F51CEB37Q27321768-8A49F7FD-877B-496F-B535-74480F3F5738Q27331693-DD5A680A-8430-4CCD-BF3E-1A5CE14614BBQ27851744-AE5C481D-AC91-44C5-BCF7-465599493FFEQ28080163-60FB05A1-B303-4C48-A3B7-136444DC6F8BQ28086904-C1ED1418-D1C1-423E-B2D2-A4EEE321D82DQ28477440-F11047B2-9AFF-4EAA-B711-B8F3E51C6F75Q28583917-372925AB-5127-46D4-A4C0-B4ED266A7FA0Q28730801-6A40B88D-F0B0-455D-91B0-6A53C24ABB28Q30358961-5A9EE900-1311-4EA6-9C00-0927C5F0D8E7Q30440705-91EA3F6B-1CDE-4C2A-AF9C-09DE9E23D49BQ30455612-BB609C02-6BC7-4254-8260-670745E41147Q30497786-A900A932-96CA-4EF3-A5D7-086426CBC0DEQ30736359-59E89D58-CC6D-49F4-A6A4-5645ADAA2AA0Q30804219-DB44DC30-FCA5-4129-95AF-0AA8EB084395Q30833091-4C5D5EC7-18B2-467B-B795-646266A055B2Q31040895-68E1ECAB-63A6-4D6A-AF8B-83EAC87CE6EFQ33382103-DC2E4B8D-4628-4F7E-990C-CF2F267F464EQ33400232-55A5E8EB-05B8-4EC5-AB63-7AB67C2CB24AQ33424482-7721C31C-784F-4B67-BFBD-9F6734597C3AQ33467424-3144267E-B845-4B87-833E-3CFDB3FA4256Q33584304-B1C1AA09-070B-4DE9-94BA-712109132C46Q33619010-0CA360D4-2B8A-4174-8974-D3562BD886FAQ33623357-334F4049-3315-45DF-9C8E-610CA30AFDAFQ33659965-EB5A68D7-BE55-49D2-AD7B-17CE9A47D08AQ33698419-1EDBEE7F-754E-41E2-9ECB-0891F2EBC30AQ33718137-44DDDC92-7D0F-4672-96B9-005D9FAC56D5Q33733437-F1711AEB-26B4-41F5-92FA-644A87995AC2Q33748993-EF607B31-4446-4D62-B2F3-33ABE6490118Q33828690-8886ADBA-38A8-4E87-95AB-499E9BCD317DQ33841397-726E64C7-005F-4D8F-A5BB-9C33C82D0749
P2860
VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
VEGF-dependent plasticity of f ...... normal adult microvasculature.
@en
VEGF-dependent plasticity of f ...... normal adult microvasculature.
@nl
type
label
VEGF-dependent plasticity of f ...... normal adult microvasculature.
@en
VEGF-dependent plasticity of f ...... normal adult microvasculature.
@nl
prefLabel
VEGF-dependent plasticity of f ...... normal adult microvasculature.
@en
VEGF-dependent plasticity of f ...... normal adult microvasculature.
@nl
P2093
P1476
VEGF-dependent plasticity of f ...... normal adult microvasculature.
@en
P2093
Amy Haskell
Barbara Sennino
Betty Y Y Tam
Calvin J Kuo
Donald M McDonald
Gavin Thurston
Hiroya Hashizume
Keith D Anderson
Lori C Gowen
Matthew L Springer
P304
P356
10.1152/AJPHEART.00133.2005
P50
P577
2005-09-19T00:00:00Z